RPBP: A GPCR-Interacting Protein with Potential Therapeutic Applications

Target Name: RENBP

NCBI ID: G5973

RENBP

RPBP: A GPCR-Interacting Protein with Potential Therapeutic Applications

RPBP (renapidine-binding protein) is a protein that is expressed in various tissues throughout the body, including the brain, spleen, and peripheral tissues. It is a member of the superfamily of G-protein-coupled receptors (GPCRs), which are a family of transmembrane proteins that play a critical role in cellular signaling.

RPBP is characterized by its ability to interact with GPCRs, particularly those that are involved in the regulation of pain, inflammation, and blood pressure. It is this interaction that makes RPBP a potential drug target, as drugs that can modulate the activity of these GPCRs have been shown to have a wide range of therapeutic applications.

RPBP has been shown to play a role in the regulation of pain perception and the modulation of pain modalities. For example, studies have shown that RPBP is involved in the regulation of nociceptive pain, which is the type of pain that is elicited by tissue damage or inflammation. Additionally, RPBP has been shown to play a role in the regulation of neuropathic pain, which is the type of pain that is caused by damage to nerves.

In addition to its role in pain regulation, RPBP has also been shown to be involved in the regulation of inflammation and blood pressure. For example, studies have shown that RPBP is involved in the regulation of inflammation in response to tissue damage, as well as in the regulation of blood pressure.

RPBP is also a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. For example, studies have shown that RPBP is expressed in the brains of patients with Alzheimer's disease, and that it is involved in the regulation of neurodegenerate diseases. Additionally, RPBP has been shown to be involved in the regulation of blood pressure in individuals with hypertension, and that it may be a potential target for therapies aimed at reducing blood pressure.

RPBP is a protein that has been shown to play a critical role in the regulation of various physiological processes in the body. As such, it is a potential drug target, and research into its mechanisms and function is an important area of research. Further studies are needed to fully understand the role of RPBP in cellular signaling and its potential as a drug target.

Protein Name: Renin Binding Protein

Functions: Catalyzes the interconversion of N-acetylglucosamine to N-acetylmannosamine (PubMed:9990133, PubMed:10502668, PubMed:12499362). Involved in the N-glycolylneuraminic acid (Neu5Gc) degradation pathway: although human is not able to catalyze formation of Neu5Gc due to the inactive CMAHP enzyme, Neu5Gc is present in food and must be degraded (PubMed:9990133)

The "RENBP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RENBP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets